Anebulo Pharmaceuticals, Inc. (ANEB)

Anebulo Pharmaceuticals Statistics

Total Valuation

ANEB has a market cap or net worth of $131.06 million. The enterprise value is $117.78 million.

Market Cap	131.06M
Enterprise Value	117.78M

Important Dates

The last earnings date was Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ANEB has 41.08 million shares outstanding. The number of shares has increased by 16.67% in one year.

Current Share Class	41.08M
Shares Outstanding	41.08M
Shares Change (YoY)	+16.67%
Shares Change (QoQ)	+49.86%
Owned by Insiders (%)	40.54%
Owned by Institutions (%)	3.87%
Float	3.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	9.74
P/TBV Ratio	9.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 25.29

Current Ratio	25.29
Quick Ratio	24.32
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-19.40

Financial Efficiency

Return on equity (ROE) is -83.37% and return on invested capital (ROIC) is -55.79%.

Return on Equity (ROE)	-83.37%
Return on Assets (ROA)	-51.45%
Return on Invested Capital (ROIC)	-55.79%
Return on Capital Employed (ROCE)	-61.16%
Revenue Per Employee	n/a
Profits Per Employee	-$2.56M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +32.92% in the last 52 weeks. The beta is -0.99, so ANEB's price volatility has been lower than the market average.

Beta (5Y)	-0.99
52-Week Price Change	+32.92%
50-Day Moving Average	1.49
200-Day Moving Average	1.46
Relative Strength Index (RSI)	82.91
Average Volume (20 Days)	1,079,548

Short Selling Information

The latest short interest is 44,313, so 0.11% of the outstanding shares have been sold short.

Short Interest	44,313
Short Previous Month	36,648
Short % of Shares Out	0.11%
Short % of Float	1.30%
Short Ratio (days to cover)	2.00

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.23M
Pretax Income	-9.35M
Net Income	-7.69M
EBITDA	n/a
EBIT	-8.23M
Earnings Per Share (EPS)	-$0.26

Balance Sheet

The company has $13.28 million in cash and n/a in debt, giving a net cash position of $13.28 million or $0.32 per share.

Cash & Cash Equivalents	13.28M
Total Debt	n/a
Net Cash	13.28M
Net Cash Per Share	$0.32
Equity (Book Value)	13.46M
Book Value Per Share	0.33
Working Capital	13.26M

Cash Flow

Operating Cash Flow	-6.75M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ANEB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.67%
Shareholder Yield	-16.67%
Earnings Yield	-5.87%
FCF Yield	n/a

Analyst Forecast

The average price target for ANEB is $8.00, which is 150.78% higher than the current price. The consensus rating is "Buy".

Price Target	$8.00
Price Target Difference	150.78%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2